| Literature DB >> 29031403 |
E Elliott1, C K Hanson2, A L Anderson-Berry1, T M Nordgren3.
Abstract
Infants developing in a pro-inflammatory intrauterine environment have a significant risk for severe complications after birth. It has been shown that omega-3 fatty acids reduce inflammation, and also reduce early preterm births and decrease risk of infant admission to the neonatal intensive care unit. However, the mechanism for omega-3 fatty acids exerting these effects was previously unknown. Recent evidence has shown that downstream products of polyunsaturated fatty acids called specialized pro-resolving mediators may mediate inflammatory physiology, thus playing an important role in maternal-fetal health. In this review, current knowledge relating to specialized pro-resolving mediators in pregnancy, delivery, and perinatal disease states will be summarized.Entities:
Keywords: Docosahexaenoic acid; Fetal health; Omega-3 fatty acid; Pregnancy; Pro-resolving lipid mediator; Resolvins
Mesh:
Substances:
Year: 2017 PMID: 29031403 PMCID: PMC5647871 DOI: 10.1016/j.plefa.2017.09.017
Source DB: PubMed Journal: Prostaglandins Leukot Essent Fatty Acids ISSN: 0952-3278 Impact factor: 4.006